Streetbeat News

Stock Prices

ACU

Shares of Acme United Corporation (ACU) have resumed trading.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 5:16 pm

MRK

Merck & Co Inc.'s stock has seen a 0.78% increase in the current session, trading at $103.50. Over the past month, the stock has increased by 1.31% and by 4.82% over the past year. The company's P/E ratio of 57.06 is higher than the aggregate P/E ratio of the Pharmaceuticals industry (26.91), indicating potential overvaluation or expected better performance.

Portfolio Pulse from Benzinga Insights

November 01, 2023 | 5:15 pm

SHC

Sotera Health reported mixed Q3 financial results and issued guidance, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 5:15 pm

STVN

Jefferies has downgraded Stevanato's stock from Buy to Hold and reduced its price target from $39 to $29. This has led to a decrease in the trading price of Stevanato shares.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 5:13 pm

SMG

Scotts Miracle-Gro reported better-than-expected Q4 financial results, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 5:12 pm

RUN

SPWR

Sunrun Inc's (NASDAQ:RUN) shares are trading lower by 2.3% possibly in sympathy with SunPower Corporation (NASDAQ:SPWR) after the latter reported worse-than-expected Q3 results. SunPower reported a 9.3% YoY revenue decline in Q3 of FY23, totaling $432.00 million, falling short of the expected $453.25 million. The company also posted an adjusted EPS loss of $(0.12), missing the expected loss of $(0.00). This could raise concerns about the sector's performance as a whole.

Portfolio Pulse from Henry Khederian

November 01, 2023 | 5:12 pm

IONQ

IonQ, Inc. (NYSE:IONQ) shares are trading higher, despite being down by over 30% in the last month. Morgan Stanley analyst Scott Fessler maintained an Equal-Weight on IonQ and lowered the price target from $16 to $12. The company's co-founder and chief scientist, Dr. Chris Monroe, is set to depart. IonQ is expected to report a loss of 18 cents per share and quarterly revenue of $4.998 million in its Q3 financial results.

Portfolio Pulse from Erica Kollmann

November 01, 2023 | 5:10 pm

CNTX

HC Wainwright has upgraded Context Therapeutics from Neutral to Buy and set a price target of $5. This has led to an increase in the trading of Context Therapeutics' shares.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 5:10 pm

VFC

VF Corporation's shares are trading lower due to continued weakness following the company's mixed Q2 financial results and issued guidance.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 5:09 pm

CCRD

CoreCard's shares are trading lower following the company's announcement of a year-over-year decrease in Q3 EPS results and worse-than-expected revenue results.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 5:08 pm